Jessica Kim Cohen

Researchers from the Broad Institute, Mass General, Stanford, and elsewhere are investigating why patients with South Asian ancestry are at increased risk.

The variant, present in the NFKB1 gene and common in the Aymara community, could help guide treatment decisions, researchers reported at ASH.

The Missouri hospital system designed its own 13-gene PGx panel, which it runs at its molecular genetics lab and calls the Kiddose PGx test.

Broad Institute and Northwestern University researchers are encouraging others to examine noncoding genes, when investigating undiagnosed rare diseases.

In a report, a working group cautioned that the program must lessen its reliance on congressional appropriations or risk "squandering" investments made so far.

The Australia-based startup wants to partner with drugmakers on biomarker-defined clinical trials and create clinical decision-support software.

Scores focused on the biochemical pathways associated with disease and pairing these scores with other risk assessments could improve predictive value, the data showed.

In the next decade, the MVP is looking forward to using its cache of data on 1 million veterans to better understand and address health disparities.

At the 2023 NSGC annual conference in Chicago, genetic counselors weighed how best to integrate their services into primary care.

Physicians are intrigued by the concept but want to see more data on the benefits of medical cannabis and on the underlying genetic links that can facilitate personalization.